EcoDrugPlus

Ensembl ID : ENSGMOG00000008288
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSGMOG00000006567
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSGMOG00000036944
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSGMOG00000036991
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSGMOG00000037160
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSGMOG00000006540
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSGMOG00000007731
Gene Symbol: -
Cross references: -
98 Possible Orthologues:

Ensembl ID : ENSGMOG00000018547
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSGMOG00000000681
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSGMOG00000011065
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSGMOG00000005883
Gene Symbol: -
Cross references: -
257 Possible Orthologues:

Ensembl ID : ENSGMOG00000005486
Gene Symbol: -
Cross references: -
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).